Recent articles

Late Tuesday evening, Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC), recommended the use of the Pfizer/BioNTech COVID-19 vaccine in children ages 5–11. This decision followed the FDA’s Emergency Use Authorization on Friday, Oct. 29th. That means that if you have a child 5 years of age or older, they […]

Help us kick off National Diabetes Awareness Month at TypeOneNation Virtual Summit on November 1, 3, and 4, from 6:00 – 8:00 pm ET. This free event is for people of all ages and stages of type 1 diabetes and their loved ones. We’re offering three nights of sessions covering important topics like Breakthrough T1D’s […]

In February, Vertex announced they were beginning a clinical trial for VX-880, their stem cell-derived therapy for use in people with type 1 diabetes (T1D). Today, they announced that the first person to receive this therapy now needs 91% less insulin 90 days after receiving an infusion of these fully differentiated cells at just half […]

Breakthrough T1D is deeply saddened at the passing of Stacey Anderson, M.D. Dr. Anderson was a tireless champion for the type 1 diabetes (T1D) community, a brilliant researcher, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, and friend. “Dr. Stacey Anderson was a tremendous diabetes champion and she will be terribly missed,” said Breakthrough […]

From T1Day (wear blue!) to social media storytelling and celebrity appearances, Breakthrough T1D has a bunch of exciting plans that you won’t want to miss out on!

Together with our supporters, we have played a key role in the discovery and availability of nearly every major T1D advance and we can’t stop now. Future breakthroughs start with us. We know many of you will soon contemplate your year-end giving and will want to make the most of your charitable dollars. Fortunately, the […]

Medtronic’s Extended Wear Infusion Set (EWIS) is the first infusion set approved for 7 days, a significantly longer duration; Currently, no other infusion set is approved for more than 3 days.

John J. McDonough was a self-made man with a successful career in business and finance. But to us, he will be remembered for his service to Breakthrough T1D and his perseverance in moving life-changing research forward for the many people living with type 1 diabetes (T1D) today. John served on our International Board of Directors […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.